Found: 7
Select item for more details and to access through your institution.
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7689, doi. 10.1007/s00432-023-04721-2
- By:
- Publication type:
- Article
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 7, p. 1957, doi. 10.1007/s00432-021-03598-3
- By:
- Publication type:
- Article
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 372, doi. 10.3390/pharmaceutics15020372
- By:
- Publication type:
- Article
Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5569, doi. 10.3390/cancers13215569
- By:
- Publication type:
- Article
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned So Far.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1448, doi. 10.3390/cancers12061448
- By:
- Publication type:
- Article
The Pyrazolo[3,4- d ]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 659, doi. 10.3390/biomedicines10030659
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma.
- Published in:
- Pharmaceutical Chemistry Journal, 2023, v. 56, n. 12, p. 1616, doi. 10.1007/s11094-023-02836-x
- By:
- Publication type:
- Article